참고자료

[돼지독감] 2009 신종플루 보고된 것보다 15배 더 사망

2009년 신종플루로 사망한 사람이 28만 4천5백명으로 추정되어 실험실 확진 사망자 수보다
15배나 더 많은 것으로 보인다는 연구결과가 <랜싯>지에 실렸습니다.

New mortality estimate for 2009 H1N1 flu pandemic

 Deaths worldwide from the 2009 influenza H1N1 pandemic were likely to be around 280,000, far higher than the 18,500 deaths reported from laboratory confirmed H1N1 influenza analysis, according to new research published in The Lancet Infectious Diseases. To reach this new global mortality estimate, the study investigators developed a new model that used influenza-specific data from 12 low, middle, and high-income countries. A separate study highlights how a H1N1 vaccination campaign was effectively implemented in Scotland, UK, during the pandemic, with implications for future pandemic preparedness.



=========================


The Lancet Infectious Diseases, Early Online Publication, 26 June 2012
doi:10.1016/S1473-3099(12)70121-4Cite or Link Using DOI

http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(12)70121-4/fulltext

Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study

Dr Fatimah S Dawood MD a , A Danielle Iuliano PhD a, Carrie Reed DSc a, Martin I Meltzer PhD b, David K Shay MD a, Po-Yung Cheng PhD a, Don Bandaranayake MBBS c, Robert F Breiman MD d, W Abdullah Brooks MD e f, Philippe Buchy MD g, Daniel R Feikin MD d, Karen B Fowler DrPH h, Aubree Gordon PhD i j, Nguyen Tran Hien MD k, Peter Horby MBBS l, Q Sue Huang PhD c, Mark A Katz MD d, Anand Krishnan MBBS m, Renu Lal PhD a, Joel M Montgomery PhD a n, Kåre Mølbak MD o, Richard Pebody MBBS p, Anne M Presanis PhD p, Hugo Razuri MD n, Anneke Steens MSc q, Yeny O Tinoco DVM n, Jacco Wallinga PhD q, Hongjie Yu MD r, Sirenda Vong MD s, Joseph Bresee MD a, Dr Marc-Alain Widdowson VetMB a

Summary

Background

18 500 laboratory-confirmed deaths caused by the 2009 pandemic influenza A H1N1 were reported worldwide for the period April, 2009, to August, 2010. This number is likely to be only a fraction of the true number of the deaths associated with 2009 pandemic influenza A H1N1. We aimed to estimate the global number of deaths during the first 12 months of virus circulation in each country.

Methods

We calculated crude respiratory mortality rates associated with the 2009 pandemic influenza A H1N1 strain by age (0—17 years, 18—64 years, and >64 years) using the cumulative (12 months) virus-associated symptomatic attack rates from 12 countries and symptomatic case fatality ratios (sCFR) from five high-income countries. To adjust crude mortality rates for differences between countries in risk of death from influenza, we developed a respiratory mortality multiplier equal to the ratio of the median lower respiratory tract infection mortality rate in each WHO region mortality stratum to the median in countries with very low mortality. We calculated cardiovascular disease mortality rates associated with 2009 pandemic influenza A H1N1 infection with the ratio of excess deaths from cardiovascular and respiratory diseases during the pandemic in five countries and multiplied these values by the crude respiratory disease mortality rate associated with the virus. Respiratory and cardiovascular mortality rates associated with 2009 pandemic influenza A H1N1 were multiplied by age to calculate the number of associated deaths.

Findings

We estimate that globally there were 201 200 respiratory deaths (range 105 700—395 600) with an additional 83 300 cardiovascular deaths (46 000—179 900) associated with 2009 pandemic influenza A H1N1. 80% of the respiratory and cardiovascular deaths were in people younger than 65 years and 59% occurred in southeast Asia and Africa.

Interpretation

Our estimate of respiratory and cardiovascular mortality associated with the 2009 pandemic influenza A H1N1 was 15 times higher than reported laboratory-confirmed deaths. Although no estimates of sCFRs were available from Africa and southeast Asia, a disproportionate number of estimated pandemic deaths might have occurred in these regions. Therefore, efforts to prevent influenza need to effectively target these regions in future pandemics.

Funding

None.


=============

2009 swine flu outbreak was 15 times deadlier: study
By Sharon Begley | Reuters – 6 hrs ago


http://news.yahoo.com/2009-swine-flu-outbreak-15-times-deadlier-study-231455317.html;_ylt=A2KJjb32SulP2jIAXL7QtDMD


NEW YORK (Reuters) – The swine flu pandemic of 2009 killed an estimated 284,500 people, some 15 times the number confirmed by laboratory tests at the time, according to a new study by an international group of scientists.


The study, published on Tuesday in the London-based journal Lancet Infectious Diseases, said the toll might have been even higher – as many as 579,000 people.


The original count, compiled by the World Health Organization, put the number at 18,500.


Those were only the deaths confirmed by lab testing, which the WHO itself warned was a gross underestimate because the deaths of people without access to the health system go uncounted, and because the virus is not always detectable after a victim dies.


The new study also shows the pandemic’s impact varied widely by region, with 51 percent of swine flu deaths occurring in Africa and southeast Asia, which account for only 38 percent of the world’s population.


“This pandemic really did take an enormous toll,” said Dr. Fatimah Dawood of the U.S. Centers for Disease Control and Prevention, who led the study. “Our results also suggest how best to deploy resources. If a vaccine were to become available, we need to make sure it reached the areas where the death toll is likely to be highest.”


Swine flu, caused by the H1N1 influenza virus, infected its first known victim in central Mexico in March 2009. By April it had reached California, infecting a 10-year-old, and then quickly spread around the world, triggering fears and even panic.


The CDC warned Americans not to travel to Mexico if they could avoid it. Egypt ordered the slaughter of all the country’s pigs in a misguided attempt to contain the virus, which was in fact spread from person to person.


The fears reflected the unusual nature of the virus, which contained bits and pieces of bird, swine and human flu viruses, a combination never before detected.


Scientists were unsure how transmissible or deadly this mongrel flu would be, but early signs were ominous: the World Health Organization declared swine flu a pandemic in June 2009, when labs had identified cases in 74 countries.


Such lab-based identification is the gold standard, but every expert acknowledges that it misses more cases than it catches.


One reason is that “some people who contract flu do not have access to health care,” said CDC’s Dawood, so their illness and even death goes unnoticed by authorities. Another reason is that the virus is not always detectable by the time a victim dies.


LACK OF DATA LOWBALLS FATALITIES


To get around these obstacles, epidemiologists resort to statistical models. They typically take the number of deaths from pneumonia and complications of underlying cardiovascular disease – both caused by influenza – during non-flu periods, count the number during a pandemic, and attribute the excess to the flu.


Unfortunately, “vital statistics data are non-existent or sparse in many lower-resource countries,” said Dawood, making this approach infeasible.


Dawood and her colleagues – from Vietnam, Kenya, New Zealand, Denmark and five other countries – tried a different method.


They started with hard data, such as numbers from health workers going door to door in rural villages and asking about flu-like symptoms and testing nasal and throat swab samples, to estimate the proportion of a country’s population infected with 2009 H1N1. Such data were available from 13 countries – wealthy, such as Denmark, and poor, like Vietnam.


Then the scientists estimated the fraction of patients who died in each country. They started with solid data on death rates from respiratory illnesses in five wealthy nations.


Since someone with, say, pneumonia has a lower chance of dying if treated in a top hospital in Hong Kong than at a rural clinic in Vietnam, the scientists applied a “multiplier” to the raw data from poor countries.


That is, they assumed that more people with flu-caused pneumonia died in developing nations than developed ones.


These estimates and assumptions can introduce errors, critics note. Newly released mortality data from Mexico, for instance, show that H1N1 killed even more people than the new study estimates, said Lone Simonsen of George Washington University School of Public Health, co-author of a commentary on the study. Estimates of deaths from Japan and Singapore, in contrast, may be too high.


Overall, however, the under- and over-estimates probably even out, said Simonsen, making the global estimate – of 15 times more deaths than those confirmed at the time – about right.


The results paint a picture of a flu virus that did not treat all victims equally.


It killed two to three times as many of its victims in Africa as elsewhere. Overall, the virus infected children most (4 percent to 33 percent), adults moderately (0 to 22 percent of those 18 to 64) and the elderly hardly at all (0 to 4 percent).


Even though the elderly were more likely to die once infected, so few caught the virus that 80 percent of swine flu deaths were of people younger than 65.


In contrast, the elderly account for roughly 80 percent to 90 percent of deaths from seasonal influenza outbreaks. They were probably spared the worst of 2009 H1N1 because the virus resembled one that had circulated before 1957, meaning people alive then had developed some antibodies to it.


The relative youth of the victims meant that H1N1 stole more than three times as many years of life than typical seasonal flu: 9.7 million years of life lost compared to 2.8 million if it had targeted the elderly as seasonal flu does.


H1N1 had begun petering out by November 2009, and the WHO declared the epidemic at an end the following August.


(Reporting by Sharon Begley; Editing by Michele Gershberg and Xavier Briand)

댓글 남기기

이메일은 공개되지 않습니다.

다음의 HTML 태그와 속성을 사용할 수 있습니다: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>